Kindbody is a leading fertility clinic network and family-building benefits provider for employers.
Kindbody is a leading fertility clinic network and family-building benefits provider for employers offering comprehensive virtual and in-person care. Kindbody's clinically-managed program includes fertility assessments and education, fertility preservation, genetic testing, in vitro fertilization (IVF), donor and surrogacy services, and adoption. Employers partner with Kindbody to provide their employees financial, medical, and emotional support as they pursue parenthood. Kindbody is the trusted fertility benefits provider for more than 100 employers, covering more than 2.4 million lives. Many thousands more receive their fertility care directly from Kindbody throughout the country at Kindbody’s network of signature clinics, mobile clinics, and partner clinics.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 6, 2022 | Series C | $26.66M | 6 | — | — | Detail |
Mar 1, 2022 | Series Unknown | $29.35M | 1 | — | — | Detail |
Jun 25, 2021 | Series C | $62M | 10 | Claritas Health Ventures | — | Detail |
Jul 8, 2020 | Series B | $32M | 9 | Perceptive Advisors | — | Detail |
Dec 12, 2019 | Series A | $10M | 2 | GV | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Claritas Health Ventures | Yes | Series C |
Marco DeMeireles | Yes | Seed |
Distributed Ventures | — | Series C |
G9 Ventures | — | Series C |
GV | — | Series C |
Perceptive Life Sciences | — | Series C |
Squarepoint Capital | — | Series C |
What If Ventures | — | Series C |
Bramalea Partners | — | Series C |
Eldridge | — | Series C |
Kindbody has acquired 3 organizations. Their most recent acquisition was Vios Fertility Institute on Feb 1, 2022. They acquired Vios Fertility Institute for 0.
Date
Company Name
|
Industry | Acquisition Type | Price | |
---|---|---|---|---|
Feb 1, 2022
Vios Fertility Institute
|
Health Care | acquisition | — | Detail |
Jun 7, 2022
Phosphorus
|
Biotechnology | acquisition | — | Detail |
Aug 1, 2022
Alternative Reproductive Resources
|
Family | acquisition | — | Detail |